ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review.

Haneul Cho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.